Core Insights - BioRestorative Therapies, Inc. is focused on regenerative medicine, particularly stem cell-based therapies and products [1][3] - The CEO, Lance Alstodt, will participate in the 3rd Annual ROTH Healthcare Opportunities Conference on October 9, 2024, in New York City [1][2] Company Overview - BioRestorative develops therapeutic products using adult stem cells, with two main clinical development programs targeting disc/spine disease and metabolic disorders [3] - The Disc/Spine Program features BRTX-100, a cell therapy candidate for treating painful lumbosacral disc disorders, currently in Phase 2 clinical trials [3] - The Metabolic Program, ThermoStem®, aims to address obesity and metabolic disorders using brown adipose-derived stem cells to generate brown adipose tissue, which may enhance caloric burning and reduce glucose and lipid levels [4] - The company also operates a BioCosmeceutical platform, offering a cell-based secretome product designed to reduce fine lines and wrinkles, with plans to expand into more aesthetic products [5]
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference